Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-079788

Options or other derivatives

  • Director acquired 196,186 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Furey John Director 2020-07-01 Grant or award · Option to purchase Ordinary Shares +196,186 196,186 D
Loading xslF345X03/a4.xml…